Boston Scientific Corporation BSX
44.02 USD +1.27 (+2.97%)
At closeNov 10, 2026, 5:27 AM EST
44.03 +0.01 +0.02%
Pre-market · Nov 10, 5:27 AM ET
43.04 Day range 44.33
39.57 52-week range 105.65
- YTD
- -53.83%
- 1 year
- -55.99%
News
benzinga.com Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.84% on an annualized basis producing an average annual return of 14.73%. Currently, Boston Scientific has a market…
zacks.com BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays Weak Boston Scientific's cyber disruption cuts Q3 growth and earnings, forcing lower 2026 guidance as management sees 2027 as the cycle's trough.
zacks.com Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth? Boston Scientific's steep valuation discount faces a major test as earnings estimates weaken, core franchises lose momentum and key growth catalysts shift to 2028.
benzinga.com TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46 TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.
benzinga.com Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45 Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.- benzinga.com Jefferies Downgrades Boston Scientific to Hold, Lowers Price Target to $46 Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.
- benzinga.com Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $48 Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $66 to $48.
benzinga.com RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52 RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.- benzinga.com Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44 Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.
- benzinga.com Leerink Partners Maintains Outperform on Boston Scientific, Lowers Price Target to $50 Leerink Partners analyst Mike Kratky maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $55 to $50.
benzinga.com UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57 UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.
benzinga.com Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45 Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
benzinga.com These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results Boston Scientific beat Q3 estimates but cut FY26 guidance; Q4 forecasts missed expectations. Analysts adjusted price targets.
benzinga.com Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51 Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.- benzinga.com BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $49 BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.
benzinga.com Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48 Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.
benzinga.com Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance Boston Scientific slips after a cyber fallout offsets a Q3 consensus beat. Management targets a 2027 cycle trough and 2030 expansion.
benzinga.com Boston Scientific Q3 2026 Earnings Call Transcript Boston Scientific (NYSE:BSX) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This content is powered by…- benzinga.com Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 Est; Lowers FY2026 Sales Guidance from $21.178B-$21.379B to $20.927B vs $21.143B Est Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 analyst estimate. Lowers FY2026 sales outlook from $21.178 billion-$21.379 billion to $20.927…
benzinga.com Boston Scientific Sees Q4 Adj EPS $0.77-$0.79 vs $0.84 Est; Sees Sales $5.127B-$5.233B vs $5.404B Est Boston Scientific (NYSE:BSX) is looking for Q4 Adj EPS of $0.77-$0.79 vs $0.84 analyst estimate. sees sales of $5.127 billion-$5.233 billion vs $5.404 billion analyst estimate.- benzinga.com Boston Scientific Q3 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $5.138B Beat $5.046B Estimate Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 2.67 percent decrease over earnings of $0.75…
benzinga.com Microsoft, Alphabet On Deck Wednesday As AI Spending, Cloud Growth Face Test Microsoft and Alphabet headline Wednesday’s reports, with investors weighing whether AI infrastructure spending is translating into durable cloud and advertising growth. GE Vernova, Amphenol, Banco…- benzinga.com Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55 Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.
- benzinga.com Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51 Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.
- tradingkey.com HIMS News Get the latest Hims & Hers Health Inc (HIMS) stock news, including earnings updates, analyst ratings, company announcements and market-moving events.
bernews.com Bermuda Stock Exchange Report: Nov 9 2026 November 9 saw 11,048 shares trade on the Bermuda Stock Exchange, valued at $109,868.00 BD. 10,000 shares were traded by LOM ...
finance.yahoo.com EOS Investors buys 163-key Hyatt Centric Faneuil Hall Boston EOS Investors, a real estate investment platform, has acquired the 163-key Hyatt Centric Faneuil Hall Boston, marking its ...
sports.yahoo.com Boston College Guard Earns Early-Season ACC Award Money Williams has been leading Boston College early in the season and has been recognized for his start. On Monday, Williams ...
- sports.yahoo.com How Shedeur Sanders, Denzel Boston, and the rest of the Browns offense graded vs. the Saints The Browns offense came alive late during the 23-22 loss to the New Orleans Saints on Sunday. Here's how the offense graded according to Pro Football Focus: (P ...
finance.yahoo.com A Fund With $2 Billion in US Equities Bought These 3 Stocks Key TakeawaysLGT Capital Partners added to Broadcom and Netflix and opened a new Boston Scientific stake. All three now trade ...
finance.yahoo.com Boston University misses revenue projections by $42M The private institution will have to change “on a much broader scale” rather than relying on one-time cuts, its CFO said ...
seekingalpha.com Blackstone: I Sense A Trap In The Premium Associated With This Name - Sell The elevator pitch that you might hear for why you should own Blackstone shares is exactly the same reason why I see a ...
royalgazette.com Shares of LOM and Allshores trade The Royal Gazette/BSX Index remained at 3,463.38 points on the Bermuda Stock Exchange. Ten thousand LOM Financial shares ...
business-standard.com Blackstone set to become key investor in IIFL Finance with 15% stake IIFL Finance promoters Nirmal Jain and R Venkataraman will invest ₹1,200 crore alongside Blackstone's proposed ₹5,000 crore ...
marketscreener.com Certain Common Stock of Blackstone Digital Infrastructure Trust Inc. are subject to a Lock-Up Agreement Ending on 10-NOV-2026. Blackstone Digital Infrastructure Trust Inc.(NYSE:BXDC) added to Russell 2000 Growth-Dynamic Index CI Sep. 17 Blackstone ...
cardiovascularbusiness.com Boston Scientific inks $455M deal with global investment firm to work on next-gen heart pump The device in question is a microaxial heart pump for the treatment of acute myocardial infarction-related cardiogenic shock.
msn.com Browns week 9 stock report: Carson Schwesinger, Denzel Boston rise as Grant Delpit falls Carson Schwesinger and Denzel Boston led the Browns in PFF's early grades against the Saints, while Grant Delpit and Tyson ...
sharewise.com EQS-News: Infineon closes FY 2026 with record quarter; expects revenue growth of more than 20 percent and a 5-percentage-point increase in profitability for FY 2027 Quarter Results/Forecast Infineon closes FY 2026 with record quarter; expects revenue growth of more than 20 percent and a ...
- ots.at EQS-News: Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders Strategic Company Decision Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders 09.11.2026 /…